R. Donald Harvey, Therica M. Miller, Patricia A. Hurley, Ramya Thota, Lora J. Black, Suanna S. Bruinooge, Leigh M. Boehmer, Mark E. Fleury, Jasmine Kamboj, Mujahid A. Rizvi, Banu E. Symington, William D. Tap, David M. Waterhouse, Laura A. Levit, Janette K. Merrill, Sheila A. Prindiville, Teri Pollastro, Jamie R. Brewer, Leslie P. Byatt, Leila Hamroun, Edward S. Kim, Nicole Holland, Grzegorz S. Nowakowski

A call to action to advance patient‐focused and decentralized clinical trials

  • Cancer Research
  • Oncology
Save to CiteDrive Show PDF

This commentary is a call to action for a concerted commitment and effort to transform clinical trials and enable people with cancer to participate in clinical trials closer to home. Three key strategies are identified to address major barriers: confront challenges with the interpretation of US Food and Drug Administration Form 1572 requirements (Statement of Investigator); broaden acceptance of local laboratories and imaging centers; and invest in the creation of effective, sustainable partnerships between research centers and local providers.

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

  • Web-based, modern reference management
  • Collaborate and share with fellow researchers
  • Integration with Overleaf
  • Comprehensive BibTeX/BibLaTeX support
  • Save articles and websites directly from your browser
  • Search for new articles from a database of tens of millions of references
Try out CiteDrive

More from our Archive